Angiogenesis in pterygium: Study of microvessel density, vascular endothelial growth factor, and thrombospondin-1

Eye

Volumn 21, Issue 8, 2007, Pages 1095-1101

  Aspiotis, M ^a   Tsanou, E ^a   Gorezis, S ^a   Loachim, E ^a   Skyrlas, A ^a   Stefaniotou, M ^a   Malamou Mitsi, V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY; THROMBOSPONDIN 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL PARAMETERS; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR DENSITY; MICROVASCULATURE; PATHOGENESIS; PROTEIN EXPRESSION; PTERYGIUM; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 34547937136     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702495     Document Type: Article

References (39)

1. Spencer WH. Ophthalmic Pathology: An Atlas and Textbook, 3rd edn. WB Saunders Co: Philadelphia, 1985, pp 304.
2. Reese AB. Tumors of the Eye, 3rd edn. Harper & Row: New York, 1976, pp 53-55.
3. Cameron ME. Histology of pterygium: An electron microscopic study. Br J Ophthalmol 1983; 67: 604-608.
4. Hill JC, Maske R. Pathogenesis of pterygium. Eye 1989; 3: 218-226 (review).
5. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Emmett EA. Corneal changes associated with chronic UV irradiation. Arch Ophthalmol 1989; 107: 1481-1484.
6. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-β and tumor necrosis factor-α in the pterygium. Acta Histochem 1996; 98: 195-201.
7. Cunliffe IA, Richardson PS, Rees RC, Rennie IG. Effect of TNF, IL-1, and IL-6, on the proliferation of human Tenon's capsule fibroblasts in tissue culture. Br J Ophthalmol 1995; 79: 590-595.
8. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235 442-447.
9. Tsanou E, Ioachim E, Stefaniotou M, Gorezis S, Charalabopoulos K, Bagh H et al. Immuncohistochemical study of angiogenesis and proliferative activity in epiretinal membranes. Int J Clin Pract 2005; 59: 1157-1161.
10. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32: 2413-2422.
11. Drovak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/ vascular endothelial growth factor, microvascular hypermeability and angiogenesis. Am J Pathol 1995, 146: 1029-1039.
12. Ferrara N, Alitalo K. Clinical application of angiogenic growth factors and their inhibitors. Nat Med 1999, 5: 1359-1364.
13. Nicosia RF. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am J Pathol 1998, 153: 11-16.
14. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
15. Senger DR, Galli SJ, Dvorak AM, Perruzz, CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-985.
16. Dvorak HF. Tumours: Wounds that do not heal - similarity between tumour stroma generation and wound healing. N Engl J Med 1983; 315: 1650-1658.
17. Unemori EN, Ferrara N, Bauer EA, Amento E. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557-562.
18. Roberts DD. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 1996; 10: 1183-1191 (review).
19. Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothehal cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J Cell Biol 1990; 111: 765-772.
20. Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res 1994; 13: 473-481.
21. Karurukonda SR, Thompson HW, Beuerman RW, Lam DS, Wilson R, Chew SJ et al. Cell cycle kinetics in pterygium at three latitudes. Br J Ophthalmol 1995; 79: 313-317.
22. Ioachim-Velogianni E, Tsironi E, Agnantis N, Datseris G, Psilas K. HLA-DR antigen expression in pterygium epithelial cells and lymphocyte subpopulations: An immunohistochemistry study. Ger J Ophthalmol 1995; 4: 123-129.
23. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingueculae, pterygia and limbal tumors. Curr Eye Res 1997; 16 1179-1192.
24. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000; 84: 212-216.
25. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci 2000; 41: 671-679.
26. Seifert P, Sekando W. Capillaries in the epithelium of pterygium. Br J Ophthalmol 1998; 82: 77-81.
27. Lee DH, Cho HJ, Kim JT, Choi JS, Joo CK. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 2001; 20 738-742.
28. Kim I, Ryan AM, Rohan R, Amano S, Agular S, Miller JW et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci 1999; 40: 2115-2121.
29. Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A et al. Angiogenesis in pterygium: Morphometric and immunohistochemical study. Curr Eye Res 2002; 25: 17-22.
30. Gebhardt M, Mentlein R, Schaudig; U, Pufe T, Recker K, Nölle B et al. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmology 2005; 112 1023-1030.
31. Jin J, Guan M, Sima J, Gao G, Zhang M, Liu Z et al. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea 2003; 22: 473-477.
32. Van Setten G, Aspiotis M, Blalock T, Grotemdorst G, Schultz G. Connective tissue growth factor in pterygium: Simultaneous presence of vascular endothelial growth factor-possible contributing factor to conjunctival scarring. Graefe's Arch Clin Exp Ophthalmol 2003, 241: 135-139.
33. Solomon A, Li DQ, Lee SB, Tseng SC. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci 2000; 41: 2154-2163.
34. Roberts AB, Sporn MB. Growth factors and transformation. Cancer Surv 1986; 5: 405-412.
35. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6: 41-48.
36. Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991; 88: 5026-5030.
37. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA et al. A tumor suppressor-dependent inhibitor of ingiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990; 87: 6624-6628.
38. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993; 122: 497-511.
39. Nicosia RF, Tuszynski GP. Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol. 1994; 124: 183-191